APA aipamena

Liu, D., Xing, J., Trink, B., & Xing, M. (2010). BRAF Mutation-selective Inhibition of Thyroid Cancer Cells by the Novel MEK Inhibitor RDEA119 and Genetic-potentiated Synergism with the mTOR Inhibitor Temsirolimus.

Chicago Style aipamena

Liu, Dingxie, Joanna Xing, Barry Trink, and Mingzhao Xing. BRAF Mutation-selective Inhibition of Thyroid Cancer Cells By the Novel MEK Inhibitor RDEA119 and Genetic-potentiated Synergism With the MTOR Inhibitor Temsirolimus. 2010.

MLA aipamena

Liu, Dingxie, Joanna Xing, Barry Trink, and Mingzhao Xing. BRAF Mutation-selective Inhibition of Thyroid Cancer Cells By the Novel MEK Inhibitor RDEA119 and Genetic-potentiated Synergism With the MTOR Inhibitor Temsirolimus. 2010.